Skip to main content
Home > The Daily Extra > Financial News

Chronological Index of : Financial News

 Current Issue
  • FINANCIAL NEWS: Biotechs pull up from Trump dive

    Biotech stocks made a partial recovery late in the week from losses incurred after President-elect Donald Trump blasted the biopharma industry during a press conference Wednesday. Trump said pharma companies are "…

    Published on 1/13/2017
  • FINANCIAL NEWS: Qiming raising $125M fund

    Qiming Venture Partners has set a $125 million target for its planned Qiming U.S. Healthcare Fund L.P., according to an SEC filing. The firm closed its fourth renminbi fund at RMB1.5 billion ($221.4 million) in November…

    Published on 1/13/2017
  • FINANCIAL NEWS: OncoImmune raises $15M in series A

    OncoImmune Inc. (Rockville, Md.) said it raised $15 million in a series A round led by 3E Bioventures Capital. The company's lead candidate, CD24Fc, is in a Phase II study to prevent graft versus host disease (GvHD). …

    Published on 1/12/2017
  • FINANCIAL NEWS: Signet closes $137.2M fourth fund

    Signet Healthcare Partners (New York, N.Y.) closed its fourth fund at $137.2 million. The firm plans to invest the fund in 10-12 commercial stage companies, primarily in the pharmaceutical and medtech sectors.The firm …

    Published on 1/12/2017
  • FINANCIAL NEWS: UCSF receives $500 million donation

    The Helen Diller Foundation donated $500 million to the University of California San Francisco. The gift is the largest ever granted to the university.The donation includes $100 million to retain existing professors and…

    Published on 1/12/2017
  • FINANCIAL NEWS: Takeda invests in cancer play Maverick, with option to buy

    Immuno-oncology company Maverick Therapeutics Inc. (Brisbane, Calif.) raised $23 million in a series B financing from founding investor MPM Capital and Takeda Pharmaceutical Co. Ltd. (Tokyo:4502). In a new partnership, …

    Published on 1/11/2017
  • FINANCIAL NEWS: Adynxx raises $16M in series B

    Pain company Adynxx Inc. (San Francisco, Calif.) raised $16 million in a series B round led by new investor TPG Biotech. Existing investor Domain Associates also participated.Adynxx said it plans to start a Phase II …

    Published on 1/10/2017
  • FINANCIAL NEWS: Labcorp buys into Sera, to distribute preterm birth test

    Sera Prognostics Inc. (Salt Lake City, Utah) raised $40 million in a series C round led by Laboratory Corp. of America Holdings (NYSE:LH). Also participating were existing investors Domain Associates, InterWest Partners…

    Published on 1/10/2017
  • FINANCIAL NEWS: Cavion raises $26.1M series A

    Cavion Inc. (Charlottesville, Va.) raised $26.1 million in a series A round co-led by Lilly Ventures and Novartis Venture Fund. Enso Ventures also participated, as did undisclosed existing investors. The company is …

    Published on 1/6/2017
  • FINANCIAL NEWS: Financial tracks

    Versant Ventures named Clare Ozawa managing director and named Alex Mayweg and Mary Haak-Frendscho venture partners. Ozawa was COO at the firm's Inception Sciences Inc. (San Diego, Calif.) company creation operation, …

    Published on 1/6/2017
  • FINANCIAL NEWS: Frontier raises RMB300M in series C

    Frontier Biotechnologies Co. Ltd. (Nanjing, China) said it raised RMB300 million ($43.2 million) in a series C round led by Huaxin Century. Shenzhen Capital, Efung Capital and undisclosed other investors also …

    Published on 1/6/2017
  • FINANCIAL NEWS: Scangos to lead anti-infectives newco Vir

    Anti-infectives company Vir Biotechnology Inc. (San Francisco, Calif.) launched with an investment round of undisclosed size. Former Biogen Inc. (NASDAQ:BIIB) CEO George Scangos will be the newco's CEO.Vir said Arch …

    Published on 1/6/2017
  • FINANCIAL NEWS: Grail seeking $1B series B round

    Cancer diagnostic company Grail Inc. (Redwood City, Calif.) said undisclosed private and strategic investors have shown interest in participating in its planned $1 billion series B round. Grail hired Goldman Sachs as a …

    Published on 1/5/2017
  • FINANCIAL NEWS: Hatteras closes fifth fund

    Hatteras Venture Partners said it closed Hatteras Venture Partners V with more than $150 million. It plans to invest in therapeutics, devices, diagnostics and healthcare IT companies, with a portion allocated to its …

    Published on 1/5/2017
  • FINANCIAL NEWS: Loxo raises $120M in follow-on

    Loxo Oncology Inc. (NASDAQ:LOXO) raised $120 million through the sale of 3.9 million shares at $31 in a follow-on underwritten by Morgan Stanley, Citigroup, Cowen and Stifel. The price is a 5% discount to Loxo's closing…

    Published on 1/5/2017
  • FINANCIAL NEWS: Neon raises $70M in series B

    Neoantigen vaccine play Neon Therapeutics Inc. (Cambridge, Mass.) raised $70 million in a series B round led by new investor Partner Fund Management. New investors Fidelity, Wellington Management, Inbio Ventures and …

    Published on 1/5/2017
  • FINANCIAL NEWS: NeRRe raises L23M in series B

    NeRRe Therapeutics Ltd. (Stevenage, U.K.) raised L23 million ($28.4 million) in an oversubscribed series B co-led by new investors Fountain Healthcare Partners, Forbion Capital Partners and OrbiMed. Also participating …

    Published on 1/5/2017
  • FINANCIAL NEWS: Shin Nippon spins out Satsuma with $12M series A

    Shin Nippon Biomedical Laboratories Ltd. (Tokyo:2395) spun out migraine company Satsuma Pharmaceuticals Inc. (San Francisco, Calif.) with a $12 million series A round co-led by RA Capital Management and TPG Biotech.…

    Published on 1/5/2017
  • FINANCIAL NEWS: CRISPR tools play Synthego raises $41M in series B

    Synthetic RNA company Synthego Corp. (Redwood City, Calif.) raised $41 million in a series B round led by 8VC. New investors AME Cloud Ventures, Elements Capital, OS Fund, Alexandria Real Estate Equities, ZhenFund, and …

    Published on 1/4/2017
  • FINANCIAL NEWS: Financial tracks

    Novo Ventures promoted Nilesh Kumar to partner from senior principal. Kumar, who is based in the firm's Boston office, was a senior director at Merck Serono Ventures prior to joining Novo Ventures in 2015.Rodman & …

    Published on 1/4/2017
  • FINANCIAL NEWS: Flagship hires ex-Novartis exec Epstein

    Flagship Pioneering named David Epstein executive partner, a newly created position. Epstein was CEO of the Novartis Pharmaceuticals unit of Novartis AG (NYSE:NVS; SIX:NOVN).Rubius Therapeutics Inc. (Cambridge, Mass.), …

    Published on 1/4/2017
  • FINANCIAL NEWS: scPharmaceuticals raises $45.6M in series B

    Drug delivery company scPharmaceuticals Inc. (Lexington, Mass.) raised $45.6 million in a series B round co-led by OrbiMed and Sun Pharmaceutical Industries Ltd. (BSE:524715; NSE:SUNPHARMA). Existing investors 5AM …

    Published on 1/4/2017
  • FINANCIAL NEWS: Ascentage raises RMB500 million series B round

    Ascentage Pharma Group Corp. Ltd. (Hong Kong, China) raised RMB500 million ($72 million) in a series B round led by Future Industry Investment Fund, a fund managed by a State Development & Investment Corp. Ltd. …

    Published on 1/3/2017
  • FINANCIAL NEWS: Clovis raises $205M in bumped-up follow-on

    Clovis Oncology Inc. (NASDAQ:CLVS) raised $205 million through the sale of 5 million shares at $41 in an upsized follow-on underwritten by JPMorgan, BofA Merrill Lynch, Stifel and SunTrust. The price is a 7.7% discount …

    Published on 1/3/2017
  • FINANCIAL NEWS: Versant closes sixth fund at $400M

    Versant Ventures (San Francisco, Calif.) closed its sixth fund at its hard cap of $400 million, above the original $350 million target. The firm plans to invest the fund in 20-25 biotechs in the U.S., Canada and Europe …

    Published on 1/3/2017

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993